Portfolio of Biotech Stocks: First Portfolio

Here is a sample of 10 biotech stocks from the universe of biotechnology companies.


10 Biotech Stocks: First Portfolio

Name
& Monthly Returns

Symbol
& Snapshot

Recent Prices
& Trendline Chart

Alnylam PharmaceuticalsALNY
AmgenAMGN
Biogen IdecBIIB
Gilead SciencesGILD
IlluminaILMN
IncyteINCY
ModernaMRNA
Regeneron PharmaceuticalsREGN
SeagenSGEN
Vertex PharmaceuticalsVRTX
Sparkline weekly price charts based on Alpha Vantage data.

10 Biotech Stocks: First Portfolio

Name
& Last 100 Days Returns

Symbol

Last Close
& 100-Day Trendline Chart

Alnylam PharmaceuticalsALNY$197.39
AmgenAMGN$226.87
Biogen IdecBIIB$195.75
Gilead SciencesGILD$62.34
IlluminaILMN$184.12
IncyteINCY$66.18
ModernaMRNA$119.69
Regeneron PharmaceuticalsREGN$686.10
SeagenSGEN$135.27
Vertex PharmaceuticalsVRTX$276.78


Portfolio Values

To inspect the performance of the Biotech Stocks: First Portfolio portfolio, see the chart below. Portfolio values are computed using monthly closes for stocks from Alpha Vantage.

The 9 stocks included in the portfolio computations are: ALNY, AMGN, BIIB, GILD, ILMN, INCY, REGN, SGEN and VRTX. The current value of the portfolio assumes that $1,111.11 was invested in each stock at its closing monthly price for the first date shown on the portfolio value chart below. All prices are adjusted for splits and dividends. MRNA was excluded from the portfolio computations because of insufficient price data.

The current value of the $10,000 investment is $13,313. The percent return is 33.13%. The annualized return is 5.89%.


9 Biotech Stocks: First Portfolio Returns

Name

Symbol

Monthly Returns & Details

Alnylam PharmaceuticalsALNY68.01%
AmgenAMGN40.97%
Biogen IdecBIIB-37.48%
Gilead SciencesGILD-6.52%
IlluminaILMN-7.57%
IncyteINCY-43.31%
Regeneron PharmaceuticalsREGN53.45%
SeagenSGEN148.61%
Vertex PharmaceuticalsVRTX82.04%


Portfolio Value Chart for Last 100 Daily Closes



Related Portfolios

Portfolio of Biotech Stocks: Second Portfolio

Portfolio of Biotech Stocks: Diabetes

Portfolio of Large Biotech Stocks